Syndicate Bio is a global genomics and precision- medicine company advancing equitable healthcare through diverse human data. We are committed to building the most inclusive health datasets globally, beginning from Africa, and translating them into actionable insights for patients, healthcare providers, and life-science partners. Through cutting-edge genomic testing, data analytics, and collaborative research, we seek to bridge the global diversity gap in precision medicine, enabling discoveries that benefit all populations.

Our Quality Management System (QMS) is designed to meet all requirements stipulated in ISO 9001:2015 and ISO 15189:2022, including compliance with all applicable ethical, statutory, and regulatory requirements. Our commitment lies in continuously improving our QMS to ensure the satisfaction of patients, healthcare providers, partners, and other stakeholders.

This Quality Policy provides the framework for setting and reviewing quality objectives and drives our pursuit of continuous improvement. It is communicated to all staff and partners, embedded in our daily operations, and periodically reviewed to ensure its suitability, adequacy, and effectiveness.